Metropolitan Life Insurance Company (MetLife)’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,729
Closed -$20.7K 2448
2022
Q1
$20.7K Sell
2,729
-4,137
-60% -$31.4K ﹤0.01% 2077
2021
Q4
$70.1K Sell
6,866
-1,576
-19% -$16.1K ﹤0.01% 2637
2021
Q3
$113K Sell
8,442
-2,645
-24% -$35.5K ﹤0.01% 2462
2021
Q2
$243K Hold
11,087
﹤0.01% 2007
2021
Q1
$267K Hold
11,087
﹤0.01% 1817
2020
Q4
$199K Hold
11,087
﹤0.01% 1937
2020
Q3
$128K Hold
11,087
﹤0.01% 2079
2020
Q2
$269K Hold
11,087
﹤0.01% 1617
2020
Q1
$122K Hold
11,087
﹤0.01% 1903
2019
Q4
$293K Sell
11,087
-513
-4% -$13.6K ﹤0.01% 1651
2019
Q3
$264K Buy
11,600
+3,935
+51% +$89.6K ﹤0.01% 1684
2019
Q2
$235K Hold
7,665
﹤0.01% 1793
2019
Q1
$127K Hold
7,665
﹤0.01% 2179
2018
Q4
$147K Buy
7,665
+847
+12% +$16.2K ﹤0.01% 2020
2018
Q3
$357K Hold
6,818
0.01% 1610
2018
Q2
$296K Buy
6,818
+2,224
+48% +$96.7K ﹤0.01% 1675
2018
Q1
$170K Buy
+4,594
New +$170K ﹤0.01% 1992